Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 19217, 2022 11 10.
Article in English | MEDLINE | ID: mdl-36357775

ABSTRACT

Bacillus circulans (B. circulans) is widely used as an electrogenic bacterium in microbial fuel cell (MFC) technology. This study evaluated whether B. circulans can ferment glucose to generate electricity and mitigate the effects of human skin pathogens. The electricity production of B. circulans was examined by measuring the voltage difference and verified using a ferrozine assay in vitro. To investigate the fermentation effects of B. circulans on inhibition of human skin pathogens, Cutibacterium acnes (C. acnes) was injected intradermally into mice ears to induce an inflammatory response. The results revealed that the glucose-B. circulans co-culture enhanced electricity production and significantly supressed C. acnes growth. The addition of roseoflavin to inhibit flavin production considerably reduced the electrical energy generated by B. circulans through metabolism and, in vivo test, recovered C. acnes count and macrophage inflammatory protein 2 (MIP-2) levels. This suggests that B. circulans can generate electrons that affect the growth of C. acnes through flavin-mediated electron transfer and alleviate the resultant inflammatory response. Our findings demonstrate that probiotics separated from natural substances and antimicrobial methods of generating electrical energy through carbon source fermentation can help in the treatment of bacterial infections.


Subject(s)
Acne Vulgaris , Honey , Probiotics , Mice , Animals , Humans , Electrons , Acne Vulgaris/therapy , Acne Vulgaris/microbiology , Propionibacterium acnes , Probiotics/pharmacology , Flavins , Glucose/pharmacology
2.
Sci Rep ; 11(1): 11980, 2021 06 07.
Article in English | MEDLINE | ID: mdl-34099789

ABSTRACT

Ultraviolet irradiation induces melanin accumulation, which can be reduced by the use of chemical whitening products. However, the associated safety concerns of such products have prompted the search for natural and harmless alternatives. This study aimed to identify a natural acidic formulation to reduce skin pigmentation. The metabolite propionic acid (CH3CH2COOH, PA) was the most abundant fatty acid in the filtrate from Pluronic F68 (PF68) fermentation of Cutibacterium acnes (C. acnes) and reduced the DOPA-positive melanocytes by significantly inhibiting cellular tyrosinase activity via binding to the free fatty acid receptor 2 (FFAR2). Moreover, 4 mM PA treatment did not alter melanocyte proliferation, indicating that it is an effective solution for hyperpigmentation, causing no cellular damage. The reduced DOPA-positive melanocytes and tyrosinase activity were also observed in mice ear skin tissue injected with a mixture of C. acnes and PF68, supporting that the inhibition of melanogenesis is likely to be mediated through fermentation metabolites from C. acnes fermentation using PF68 as a carbon source. Additionally, PA did not affect the growth of its parent bacteria C. acnes, hence is a potent fermentation metabolite that does not disrupt the balance of the skin microbiome.


Subject(s)
Melanins/chemical synthesis , Propionates/metabolism , Propionibacterium acnes/metabolism , Animals , Cell Proliferation , Ear , Female , Fermentation , Humans , Hyperpigmentation , Melanocytes/cytology , Melanocytes/metabolism , Metabolome , Mice, Inbred ICR , Photochemical Processes , Propionates/chemistry , Receptors, G-Protein-Coupled/radiation effects , Skin , Skin Pigmentation , Ultraviolet Rays
3.
Toxins (Basel) ; 11(6)2019 05 31.
Article in English | MEDLINE | ID: mdl-31159213

ABSTRACT

The microbiome is a rich source of metabolites for the development of novel drugs. Butyric acid, for example, is a short-chain fatty acid fermentation metabolite of the skin probiotic bacterium Staphylococcus epidermidis (S. epidermidis). Glycerol fermentation of S. epidermidis resulted in the production of butyric acid and effectively hindered the growth of a Staphylococcus aureus (S. aureus) strain isolated from skin lesions of patients with atopic dermatitis (AD) in vitro and in vivo. This approach, however, is unlikely to be therapeutically useful since butyric acid is malodorous and requires a high concentration in the mM range for growth suppression of AD S. aureus. A derivative of butyric acid, BA-NH-NH-BA, was synthesized by conjugation of two butyric acids to both ends of an -NH-O-NH- linker. BA-NH-NH-BA significantly lowered the concentration of butyric acid required to inhibit the growth of AD S. aureus. Like butyric acid, BA-NH-NH-BA functioned as a histone deacetylase (HDAC) inhibitor by inducing the acetylation of Histone H3 lysine 9 (AcH3K9) in human keratinocytes. Furthermore, BA-NH-NH-BA ameliorated AD S. aureus-induced production of pro-inflammatory interleukin (IL)-6 and remarkably reduced the colonization of AD S. aureus in mouse skin. These results describe a novel derivative of a skin microbiome fermentation metabolite that exhibits anti-inflammatory and S. aureus bactericidal activity.


Subject(s)
Anti-Bacterial Agents/pharmacology , Butyrates/pharmacology , Dermatitis, Atopic/microbiology , Histone Deacetylase Inhibitors/pharmacology , Staphylococcus aureus/drug effects , Animals , Cell Line , Female , Fermentation , Glycerol/metabolism , Histones/metabolism , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice, Inbred ICR , Skin/microbiology , Staphylococcus aureus/growth & development , Staphylococcus epidermidis/metabolism
4.
Int J Mol Sci ; 19(5)2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29693635

ABSTRACT

Unlike USA300, a strain of community-acquired methicillin-resistant Staphylococcus aureus (MRSA), commensal Staphylococcus aureus (S. aureus) bacteria isolated from human skin demonstrated the ability to mediate the glycerol fermentation to produce short-chain fatty acids (SCFAs). Quantitative proteomic analysis of enzymes involved in glycerol fermentation demonstrated that the expression levels of six enzymes, including glycerol-3-phosphate dehydrogenase (GPDH) and phosphoglycerate mutase (PGM), in commensal S. aureus are more than three-fold higher than those in USA300. Western blotting validated the low expression levels of GPDH in USA300, MRSA252 (a strain of hospital-acquired MRSA), and invasive methicillin-susceptible S. aureus (MSSA). In the presence of glycerol, commensal S. aureus effectively suppressed the growth of USA300 in vitro and in vivo. Active immunization of mice with lysates or recombinant α-hemolysin of commensal S. aureus or passive immunization with neutralizing sera provided immune protection against the skin infection of USA300. Our data illustrate for the first time that commensal S. aureus elicits both innate and adaptive immunity via glycerol fermentation and systemic antibody production, respectively, to fight off the skin infection of pathogenic MRSA.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/immunology , Microbiota/immunology , Staphylococcal Skin Infections/immunology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cells, Cultured , Female , Glycerol/metabolism , Glycerolphosphate Dehydrogenase/genetics , Glycerolphosphate Dehydrogenase/metabolism , Immunization, Passive , Mice , Mice, Inbred ICR , Phosphoglycerate Mutase/genetics , Phosphoglycerate Mutase/metabolism , Skin/immunology , Skin/microbiology , Staphylococcal Skin Infections/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...